Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

14
Nissan to boost China production capacity by 40 percent: source

4m japantimes.co.jp
BEIJING – Nissan Motor Co. plans to invest about $900 million to boost vehicle-making capacity in China by 40 percent by 2021 — part of a 60 billion yuan ($8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

14
Foreign automakers oppose Donald Trump NAFTA plan as US-Mexico talks resume

2h moneycontrol
Foreign-brand automakers with US plants do not support Trump administration rules to raise the amount of local content in North American-made vehicles, a group representing companies including Toyota Motor Corp, Volkswagen AG and Hyundai Motor Co has told key US lawmakers.
HYUO TM GELYF TYT GELYY TOYOF HYUD 0175 VLKAF 7203 HYUP GM

0
Maruti Suzuki wants suppliers to sell spare parts through dealerships, service centres

3h livemint
New Delhi: In its quest to improve dealer profitability, Maruti Suzuki India Ltd has created a royalty vertical in its spare parts department wherein the company will offer the option to its vendors—such as tyre makers, engine oil suppliers and battery makers—to sell their wares directly through authorized dealerships and service centres, said two people familiar with the matter.
TM MARUTI 7269 7203 TYT TOYOF MRZUY 532500

14
Foreign automakers oppose Trump NAFTA plan as U.S.-Mexico talks resume

5h japantimes.co.jp
WASHINGTON – Foreign-brand automakers with U.S. plants do not support Trump administration rules to raise the amount of local content in North American-made vehicles, a group representing companies including Toyota Motor Corp., Volkswagen AG and Hyundai Motor Co. has told key U.S. lawmakers.
HYUO TM GELYF TYT KIMTY GELYY TOYOF DDAIF HYUD 0175 VLKAF KIMTF 7203 HYUP GM

14
Foreign automakers oppose Trump NAFTA plan as U.S-Mexico talks resume

8h reuters
WASHINGTON (Reuters) - Foreign-brand automakers with U.S. plants do not support Trump administration rules to raise the amount of local content in North American-made vehicles, a group representing companies including Toyota Motor Corp (7203.T), Volkswagen AG (VOWG_p.DE) and Hyundai Motor Co (005380.KS) has told key U.S. lawmakers.
HYUO TM GELYF TYT KIMTY GELYY TOYOF HYUD 0175 VLKAF KIMTF 7203 HYUP GM

14
Foreign automakers oppose Trump NAFTA plan as U.S-Mexico talks resume

8h channelnewsasia
Foreign-brand automakers with U.S. plants do not support Trump administration rules to raise the amount of local content in North American-made vehicles, a group representing companies including Toyota Motor Corp , Volkswagen AG and Hyundai Motor Co has told key U.S. lawmakers.
HYUO TM GELYF TYT GELYY TOYOF HYUD 0175 VLKAF 7203 HYUP GM

14
Nissan to boost China production capacity by 40%, source says

16h theedgemarkets
BEIJING (Aug 20): Japan's Nissan Motor Co plans to invest about US$900 million to boost vehicle-making capacity in China by 40% by 2021 — part of a 60 billion yuan (US$8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

14
Nissan to boost China production capacity by 40 percent, source says

19h channelnewsasia
Japan's Nissan Motor Co plans to invest about US$900 million to boost vehicle-making capacity in China by 40 percent by 2021 - part of a 60 billion yuan (US$8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

14
UPDATE 1-Nissan to boost China production capacity by 40 pct, source says

19h reuters
BEIJING (Reuters) - Japan’s Nissan Motor Co (7201.T) plans to invest about $900 million to boost vehicle-making capacity in China by 40 percent by 2021 - part of a 60 billion yuan ($8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

136
Revisiting the Trump Portfolios - The Big Picture

19h ritholtz
Betting Against Trump Was a Market-Beater The companies the president disparaged have done much better than those he favored. Bloomberg, January 10, 2018
STZ.B XOM TWX GLSSP TWTR JBK TMUSP TMUS TFG TYT STZ UTX TWC 7203 9984 BA LMT FB TM PYPL SFTBF GS BOE GM SFTBY CLNS GSC NYTAB TOYOF GSJ S RXN PEP CLNY TSLA GJS

0
Toyota to Expand Guangzhou & Tianjin Hubs' Capacity in China

19h zacks
Toyota Motor Corporation (TM - Free Report) is going to expand the capacity at the Guangzhou facility in China, per Reuters. This is in addition to the production expansion at another hub in Tianjin by around 120,000 units per year. The capacity increase at Toyota’s Guangzhou hub will help manufacture an additional 120,000 vehicles a year. Combining the production increase of Tianjin and Guangzhou plants, the company will raise its overall manufacturing capacity by 20% or 240,000 units per year.
CMQMY TM 7203 TYT PCAR TOYOF CMI

0
Nikkei falls as chip-related stocks weaken

2018-08-20 thehindubusinessline
The Nikkei share average dropped 0.2 per cent to 22,230.46 at the midday break. - Reuters
PCRFY ITOCY ADTTF TM TYT TOYOF TOELY SUOPY ITOCF 7203 SUMCF 8035 TOELF ATEYY

0
Nikkei falls as chip-related stocks weigh; market focuses on U.S.-China talks

2018-08-20 reuters
TOKYO, Aug 20 (Reuters) - Japan’s Nikkei fell on Monday morning as chip-related stocks weakened, tracking their U.S. peers’s declines on Friday, while investors awaited developments from trade talks scheduled between the United States and China this week.
PCRFY ITOCY ADTTF TM TYT TOYOF TOELY SUOPY ITOCF 7203 SUMCF 8035 TOELF ATEYY

14
New Hoong Fatt ramps up overseas expansion

2018-08-20 theedgemarkets
KUALA LUMPUR: New Hoong Fatt Holdings Bhd (NHF), unfazed by local debate over a third national car, is not overly concerned about talks of policy changes in the local automotive market as it expands its opportunities in Asean.
TM 7060 7203 TYT GM TOYOF

0
Toyota ordered to pay family US$242mil for Lexus seat defect

2018-08-19 thestar.com.my
DALLAS: A Texas jury hit Toyota with a US$242mil verdict after finding that defects in the front seats of a 2002 Lexus ES300 caused serious injuries to a Dallas family’s two young children during a rear-end collision in 2016.
TM 7203 TYT TOYOF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 892331307